Exact Sciences (NASDAQ: EXAS) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Trader Talk

Whitney Tilson Says Exact Sciences (EXAS) Still a Great ShortOctober 7, 2015 10:20 AM Mizuho Securities Cuts Price Target on Exact Sciences (EXAS) to $12 Following USPSTF Cologuard Guidelines October 7, 2015 6:50 AM Lake Street Capital Markets Downgrades Exact Sciences (EXAS) to HoldOctober 6, 2015 1:44 PM Exact Sciences (EXAS) PT Lowered to $15 at Roth Capital, Recommends Buying on WeaknessOctober 6, 2015 12:14 PM Exact Sciences (EXAS) PT Slashed to $11 at Goldman Sachs on Negative USPSTF RulingOctober 6, 2015 9:32 AM Canaccord Genuity Reiterates Buy on Exact Sciences (EXAS) Following USPSTF's Draft Recommendation for Colorectal Screening Guidelines October 6, 2015 8:45 AM Benchmark Downgrades Exact Sciences (EXAS) to HoldOctober 6, 2015 8:03 AM Exact Sciences to Host Webcast and Conference Call Regarding U.S. Preventive Services Task Force Draft RecommendationsOctober 6, 2015 7:50 AM USPSTF Draft Recommendation Not as Bullish as Expected for Exact Sciences (EXAS), Wedbush Says; But Would Buy Below $18October 6, 2015 7:25 AM Impact on Exact Sciences (EXAS) from USPSTF Guidlines 'Unclear', Jefferies Says; Would Be Buyers on WeaknessOctober 6, 2015 6:53 AM Exact Sciences (EXAS) Issues Statement on USPSTF Colorectal Cancer Screening Draft RecommendationOctober 6, 2015 6:29 AM Exact Sciences (EXAS) Pleased Cologuard Included in USPSTF Draft Colorectal Cancer Screening GuidelinesOctober 6, 2015 6:28 AM